FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

398748005: Product containing aspirin and caffeine and propoxyphene hydrochloride (medicinal product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1778256018 Aspirin + caffeine + propoxyphene hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3490602017 Product containing aspirin and caffeine and propoxyphene hydrochloride (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3494787013 Product containing aspirin and caffeine and propoxyphene hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    4233341000005113 acetylsalicylsyre + caffein + propoxyphenhydrochlorid da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    acetylsalicylsyre + caffein + propoxyphenhydrochlorid Is a kombinationspræparat med acetylsalicylsyre false Inferred relationship Some
    acetylsalicylsyre + caffein + propoxyphenhydrochlorid Is a Product containing caffeine (medicinal product) false Inferred relationship Some
    acetylsalicylsyre + caffein + propoxyphenhydrochlorid Is a Product containing dextropropoxyphene (medicinal product) false Inferred relationship Some
    acetylsalicylsyre + caffein + propoxyphenhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Xanthine false Inferred relationship Some
    acetylsalicylsyre + caffein + propoxyphenhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dextropropoxyphene (substance) false Inferred relationship Some
    acetylsalicylsyre + caffein + propoxyphenhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Aspirin (substance) false Inferred relationship Some
    acetylsalicylsyre + caffein + propoxyphenhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Opiate agonist (substance) false Inferred relationship Some
    acetylsalicylsyre + caffein + propoxyphenhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Stimulant (substance) false Inferred relationship Some
    acetylsalicylsyre + caffein + propoxyphenhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Caffeine false Inferred relationship Some
    acetylsalicylsyre + caffein + propoxyphenhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bronchodilator (substance) false Inferred relationship Some
    acetylsalicylsyre + caffein + propoxyphenhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Opioid receptor agonist false Inferred relationship Some
    acetylsalicylsyre + caffein + propoxyphenhydrochlorid Is a propoxyphenhydrochlorid false Inferred relationship Some
    acetylsalicylsyre + caffein + propoxyphenhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phosphodiesterase inhibitor false Inferred relationship Some
    acetylsalicylsyre + caffein + propoxyphenhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dextropropoxyphene hydrochloride false Inferred relationship Some
    acetylsalicylsyre + caffein + propoxyphenhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Xanthine false Inferred relationship Some
    acetylsalicylsyre + caffein + propoxyphenhydrochlorid Is a Product containing aspirin (medicinal product) false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) Is a False acetylsalicylsyre + caffein + propoxyphenhydrochlorid Inferred relationship Some
    Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Is a False acetylsalicylsyre + caffein + propoxyphenhydrochlorid Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start